We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Multiple Myeloma Subtypes Linked to Patient Ancestry

By LabMedica International staff writers
Posted on 23 Oct 2018
Print article
Image: The Invitrogen Qubit 4 Fluorometer is the next generation of the popular benchtop fluorometer designed to accurately measure DNA, RNA, and protein quantity (Photo courtesy of Thermo Fisher Scientific).
Image: The Invitrogen Qubit 4 Fluorometer is the next generation of the popular benchtop fluorometer designed to accurately measure DNA, RNA, and protein quantity (Photo courtesy of Thermo Fisher Scientific).
Multiple myeloma (MM) is two- to three-fold more common in African Americans compared to European Americans. This striking disparity, one of the highest of any cancer, may be due to underlying genetic predisposition between these groups.

African Americans (AAs) have a 2–3-fold higher prevalence of monoclonal gammopathy of undetermined significance (MGUS) and a similarly higher incidence of MM, along with approximately 4-year younger age of onset compared to European Americans (EAs).

An international team of scientists led by those at the Mayo Clinic (Rochester, MN, USA) performed cytogenetic analyses, genotyping, and genetic ancestry profiling on samples from 881 individuals with monoclonal gammopathy, a set of blood plasma cell neoplasms ranging from non-cancerous conditions that increase myeloma risk, such as MGUS to multiple myeloma itself. Patients were identified who had an abnormal plasma cell proliferative disorder fluorescence in situ hybridization (FISH) result and a concurrent conventional G-banded chromosome evaluation as part of routine clinical testing.

DNA was isolated from fixed cell pellets from residual chromosome studies that yielded normal results using the DNeasy Blood and Tissue Kit. DNA was quantitated using a Qubit Fluorometric Quantitation Instrument and 100 ng of DNA (5 ng/μL) was used for genotyping on a 96-well Axiom array, the Precision Medicine Research Array (PMRA).

The scientists estimated that the risk of developing one of three multiple myeloma subtypes, marked by the so-called t(11;14), t(14;16), and t(14;20) translocations, affecting an immunoglobulin heavy chain gene on chromosome 14, jumped by roughly 6% for each 10% increase in African ancestry. Compared to 235 individuals with less than 0.1% African ancestry according to their genomes, the individuals with at least 80% African ancestry also appeared less likely to develop multiple myelomas marked by trisomies and specific chromosome 13 alterations.

The authors concluded that future studies will include enlarging their 80% or greater African ancestry cohort and increasing the granularity of their studies with regards to specific regions within Africa. Understanding the cause of health disparities in monoclonal gammopathies has the potential to provide previously unrecognized interventions. The study was published on October 10, 2018, in the Blood Cancer Journal.

Related Links:
Mayo Clinic

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.